Svenska
Boston
An independent LDT provider
Home
About us
Home
About us
Learn more
Vision and mission
Leadership
About us
Leadership
Learn more
Board of directors
Management team
Medical Advisory Board
Collaborations
About us
Collaborations
Learn more
Patient Advocacy Support
Immunovia, Inc.
Immunovia Dx Laboratory, Lund
Company history
Sustainability
About us
Sustainability
Learn more
Sustainability report
Code of conduct
Work environment
Diversity
Calendar
Careers
IMMray™ Platform
Home
IMMray™ Platform
Learn more
Technology
Production
Pancreatic Cancer
IMMray™ Platform
Pancreatic Cancer
Learn more
Pancreatic cancer high risk groups
Clinical performance
Clinical prospective study program
Current technologies for detection and diagnosis
Pipeline
IMMray™ Platform
Pipeline
Learn more
Lung cancer
Investors
Media
Home
Media
Learn more
Press releases
Presentations
Webinars
Tutorials
Videos
Audio
Publications
Social media
Media resources
Partnering
Contact Us
Subscribe
Immunovia Inc
English
Svenska
Press releases
Show
All
Regulatory
R = Regulatory
November 30, 2021
Immunovia’s CEO to step down during 2022
R
November 11, 2021
Immunovia Publishes Report for the Third Quarter 2021
R
October 15, 2021
Immunovia Appoints New Chief Financial Officer
R
August 19, 2021
Immunovia Publishes Report for the Second Quarter 2021
R
May 6, 2021
Annual General Meeting – Immunovia AB
R
February 17, 2021
Immunovia Full Year Report 2020
R
December 2, 2020
Invitation to telephone conference in response to Dagens Industri’s ...
R
November 17, 2020
Chief Executive Officer, Patrik Dahlen Buys Immunovia Shares
R
November 12, 2020
Immunovia Reports Third Quarter Interim Report January – September...
R
November 2, 2020
Immunovia Provides Complementary Details on the IMMray[™] PanCan-d...
R
October 30, 2020
Change in the Number of Shares and Votes in Immunovia AB (publ)
R
October 26, 2020
Immunovia Announces Completion of Analysis from the IMMray[™]...
R
1
2
3
…
12
>
Home
Press releases
